Overview

A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Prospective open label, randomised, parallel group, comparative pilot.
Phase:
Phase 4
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Follicle Stimulating Hormone
Menotropins